source Post navigation GLP-1 Agents' Risks and Benefits Broader Than Previously Thought – Medpage Today Poxel Announces the Grant of Patent in China Protecting the Use of Imeglimin for Type-2 Diabetic Patients with Renal Impairment – BioSpace